Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2011, Article ID 651906, 4 pages
http://dx.doi.org/10.1155/2011/651906
Case Report

Good Clinical Response in a Rare Aggressive Hematopoietic Neoplasm: Plasmacytoid Dendritic Cell Leukemia with No Cutaneous Lesions Responding to 4 Donor Lymphocyte Infusions Following Transplant

1Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
2Division of Hematology-Oncology, Mount Sinai Medical Center, 1425 Madison Avenue, New York City, NY 10029, USA

Received 24 August 2011; Accepted 18 September 2011

Academic Editors: M. G. H. Betjes and M. Sadeghi

Copyright © 2011 Amir Steinberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kantarjian, D. Thomas, S. O'Brien et al., “Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia,” Cancer, vol. 101, no. 12, pp. 2788–2801, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. Linker, L. Damon, C. Ries, and W. Navarro, “Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 20, no. 10, pp. 2464–2471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Garnache-Ottou, J. Feuillard, and P. Saas, “Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?” British Journal of Haematology, vol. 136, no. 4, pp. 539–548, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. J. Borowitz, M.-C. Bene, N. L. Harris, A. Porwit, and E. Matutes, “Acute leukaemias of ambiguous lineage,” in WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 150–155, IARC Press, Lyon, France, 2008. View at Google Scholar
  5. F. Fachetti, “Blastic plasmacytoid dendritic cell neoplasm,” in Hematopathology, E. Jaffe, N. L. Harris, J. W. Vardiman, E. Campo, and D. A. Arber, Eds., pp. 788–798, Saunders, Philadelphia, PA, USA, 2011. View at Google Scholar
  6. M. Herling, M. A. Teitell, R. R. Shen, L. J. Medeiros, and D. Jones, “TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin,” Blood, vol. 101, no. 12, pp. 5007–5009, 2003. View at Google Scholar · View at Scopus
  7. L. Chaperot, N. Bendriss, O. Manches et al., “Identification of a leukemic counterpart of the plasmacytoid dendritic cells,” Blood, vol. 97, no. 10, pp. 3210–3217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Fachetti, D. M. Jones, and T. Petrella, “Blastic plasmacytoid dendritic cell neoplasm,” in WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 145–147, IARC Press, Lyon, France, 2008. View at Google Scholar
  9. M. C. Jacob, L. Chaperot, P. Mossuz et al., “CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells,” Haematologica, vol. 88, no. 8, pp. 941–955, 2003. View at Google Scholar · View at Scopus
  10. J. Feuillard, M. C. Jacob, F. Valensi et al., “Clinical and biologic features of CD4+CD56+ malignancies,” Blood, vol. 99, no. 5, pp. 1556–1563, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Herling and D. Jones, “CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells,” American Journal of Clinical Pathology, vol. 127, no. 5, pp. 687–700, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. Petrella, M. Bagot, R. Willemze et al., “Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review,” American Journal of Clinical Pathology, vol. 123, no. 5, pp. 662–675, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Male, M. B. Davis, J. P. McGuirk et al., “Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission,” International Journal of Hematology, vol. 92, no. 2, pp. 398–400, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Voelkl, M. Flaig, T. Roehnisch, N. Alpay, R. Schmidmaier, and F. Oduncu, “Blastic plasmacytoid dendritic cell neoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration,” Leukemia Research, vol. 35, no. 6, pp. e61–e63, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Dietrich, M. Andrulis, U. Hegenbart et al., “Blastic plasmacytoid dendritic cell neoplasia (BPDCN) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity,” Biology of Blood and Marrow Transplantation, vol. 17, no. 8, pp. 1250–1254, 2011. View at Publisher · View at Google Scholar · View at PubMed
  16. S. Dietrich, U. Hegenbart, T. Schmitt et al., “Unrelated donor reduced-intensity stem cell transplantation is a promising treatment option for elderly patients with blastic plasmacytoid dendritic cell neoplasm (BPDC),” Biology of Blood and Marrow Transplantation, vol. 16, no. 2, pp. S232–S233, 2010. View at Google Scholar